Brief: Conmed Q2 EPS USD 0.43
26/07/2023 21:05
Jul 26 (Reuters) - Conmed Q2 pretax profit USD 17.421 million. * Q2 sales USD 317.652 million vs. IBES estimate USD 306.1 million * Q2 income from operations USD 27.418 million * Q2 net income USD 13.732 million * Outlook FY Adjusted EPS USD 3.4-3.55
Recent news on Conmed
See all newsBrief: Conmed Enters Agreements To Repurchase 2.25% Convertible Senior Notes Due 2027 On June 3 - SEC Filing
Brief: Conmed Enters First Omnibus Amendment And Increased Facility Activation Notice On May 27, 2026 - SEC Filing
Brief: Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors
Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance
Brief: Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED